Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$459K Buy
2,795
+110
+4% +$18.3K 0.11% 96
2016
Q4
$393K Buy
2,685
+600
+29% +$90.3K 0.1% 100
2016
Q3
$348K Buy
2,085
+50
+2% +$8.46K 0.1% 91
2016
Q2
$310K Sell
2,035
-11
-0.5% -$1.71K 0.08% 109
2016
Q1
$307K Hold
2,046
0.08% 105
2015
Q4
$332K Buy
2,046
+11
+0.5% +$1.73K 0.09% 104
2015
Q3
$281K Hold
2,035
0.08% 102
2015
Q2
$312K Sell
2,035
-300
-13% -$48.1K 0.08% 103
2015
Q1
$373K Sell
2,335
-500
-18% -$78.7K 0.09% 108
2014
Q4
$452K Sell
2,835
-800
-22% -$125K 0.11% 102
2014
Q3
$511K Buy
3,635
+1,141
+46% +$149K 0.12% 95
2014
Q2
$295K Hold
2,494
0.08% 102
2014
Q1
$308K Buy
2,494
+85
+4% +$10.3K 0.08% 99
2013
Q4
$275K Hold
2,409
0.07% 108
2013
Q3
$270K Hold
2,409
0.08% 97
2013
Q2
$238K Buy
+2,409
New +$250K 0.07% 105

Other funds holding AMGN

Agran Libbie's AMGN Position: Q1 2017 in Review

Agran Libbie increased its Amgen (AMGN) stake by 4.1% in Q1 2017, buying an estimated $18.3K and bringing the position to 2,795 shares worth $459K. The position accounts for 0.11% of the portfolio, ranked #96.

Agran Libbie first reported a position in AMGN in Q2 2013 and has held it in 16 quarters since. The position peaked at $511K in Q3 2014. 1,600 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.

  • Agran Libbie held 2,795 shares of Amgen worth $459K as of Q1 2017.
  • Agran Libbie bought 110 Amgen shares in Q1 2017, an estimated $18.3K.
  • Amgen made up 0.11% of Agran Libbie's portfolio in Q1 2017, its #96 holding.
  • Agran Libbie first reported a position in Amgen in Q2 2013 and has held it in 16 quarters since.
  • Agran Libbie's Amgen position peaked at $511K in Q3 2014.
  • 1,600 funds tracked by Wall St. Rank held Amgen as of Q1 2017.

Based on Agran Libbie's 13F filing for Q1 2017, filed 27 Apr 2017.